Johnson & Johnson Beats Earnings Forecast; Vaccine Sales Top $160 Million

4 months ago 42
Publish date:Jul 21, 2021 6:35 AM EDT

"Our second-quarter results showcase Johnson & Johnson's diversified portfolio, driven by beardown income and net maturation crossed our Medical Device, Consumer Health and Pharmaceutical businesses," said CEO Alex Gorsky.

Johnson & Johnson  (JNJ) - Get Report posted stronger-than-expected 2nd 4th net Wednesday, portion boosting its full-year nett forecast, arsenic coagulated rebounds successful pharmaceutical and user wellness income boosted the group's apical and bottommost lines.

Johnson & Johnson said adjusted net for the 3 months ending successful June were pegged astatine $2.48 cents per share, up 48.5% from the aforesaid play past twelvemonth and good up of the Street statement forecast of $2.27 per share. Group revenues, Johnson & Johnson said, roseate 27% to $23.3 billion, again besting analysts' estimates of a $22.2 cardinal tally.

Vaccine sales, Johnson & Johnson said, reached $164 million, up 64% from the archetypal 4th tally. 

Looking into the 2nd fractional of the year, Johnson & Johnson said it sees adjusted net successful the portion of $9.50 to $9.60 per share, up from a anterior forecast of betwixt $9.42 and $9.57, with income successful the portion of $92.5 cardinal to $93.3 billion.

"Our second-quarter results showcase Johnson & Johnson's diversified portfolio, driven by beardown income and net maturation crossed our Medical Device, Consumer Health and Pharmaceutical businesses," said CEO Alex Gorsky. "I'm truthful arrogant of our 136,000 colleagues who stay focused connected delivering our medicines and products to patients and consumers astir the world, successful summation to advancing our pipeline with caller merchandise launches and regulatory submissions."

"These accomplishments exemplify our committedness to advancing transformational innovations that amended the wellness of radical and communities everyplace portion continuing to present semipermanent worth to each of our stakeholders," helium added.  

Johnson & Johnson shares were marked 0.92% higher successful pre-market trading instantly pursuing the net merchandise to bespeak an opening doorbell terms of $170.00 each.

Read Entire Article